Giorgio E Gerunda
Overview
Explore the profile of Giorgio E Gerunda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
1037
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rompianesi G, Montalti R, Cautero N, De Ruvo N, Stafford A, Bronzoni C, et al.
Transpl Int
. 2015 Mar;
28(7):864-9.
PMID: 25790037
Neurological complications (NCs) can frequently and significantly affect morbidity and mortality of liver transplant (LT) recipients. We analysed incidence, risk factors, outcome and impact of the immunosuppressive therapy on NC...
2.
Biselli M, DallAgata M, Gramenzi A, Gitto S, Liberati C, Brodosi L, et al.
Liver Int
. 2014 Mar;
35(1):184-91.
PMID: 24650058
Background & Aims: The model for end-stage liver disease (MELD) is used for organ allocation in liver transplantation (LT), but its prognostic performance is less accurate in patients with low...
3.
Guerrini G, Gerunda G, Montalti R, Ballarin R, Cautero N, De Ruvo N, et al.
Liver Int
. 2014 Feb;
34(6):e96-e104.
PMID: 24517642
Background & Aims: Salvage liver transplantation (SLT) is an attractive sequential strategy which combines liver resection (LR) for hepatocellular carcinoma (HCC), followed by liver transplant (LT) in the event of...
4.
Angelico M, Nardi A, Romagnoli R, Marianelli T, Ginanni Corradini S, Tandoi F, et al.
Dig Liver Dis
. 2014 Jan;
46(4):340-7.
PMID: 24411484
Background: To generate a robust predictive model of Early (3 months) Graft Loss after liver transplantation, we used a Bayesian approach to combine evidence from a prospective European cohort (Liver-Match)...
5.
Montalti R, Mimmo A, Rompianesi G, Di Gregorio C, Serra V, Cautero N, et al.
Transplantation
. 2013 Sep;
97(2):220-6.
PMID: 24056629
Background: Prognostic factors for hepatocellular carcinoma (HCC) recurrence after liver transplantation (LT) are still a matter of debate. The absence of viable tumor in the native liver, due to effectiveness...
6.
Di Benedetto F, Tarantino G, Ercolani G, Baccarani U, Montalti R, De Ruvo N, et al.
Oncologist
. 2013 May;
18(5):592-9.
PMID: 23666950
Background: The aim of our work is to assess the clinical outcomes of liver transplantation (LT) for hepatocellular carcinoma (HCC) in HIV-coinfected patients. This is a multicenter study involving three...
7.
Schlitt H, Jonas S, Ganten T, Grannas G, Moench C, Rauchfuss F, et al.
Clin Transplant
. 2013 Feb;
27(3):368-78.
PMID: 23405863
The benefits of calcineurin inhibitor (CNI)-sparing regimens on renal function following liver transplantation (LT) have been demonstrated in clinical studies. This observational study assessed the real-life effects of mycophenolate mofetil...
8.
Di Benedetto F, Tarantino G, Montalti R, Ballarin R, DAmico G, Di Sandro S, et al.
J Laparoendosc Adv Surg Tech A
. 2012 May;
22(4):400-2.
PMID: 22577807
Background: The caudate lobe, because of its location and its highly unpredictable vascular anatomy, is one of the most surgical challenging segment of the liver. Hepatocellular carcinoma (HCC) of the...
9.
Di Benedetto F, Ballarin R, Spaggiari M, Pecchi A, Gerunda G
J Surg Oncol
. 2012 Jan;
105(8):859-60.
PMID: 22215475
No abstract available.
10.
Di Benedetto F, Berretta M, De Ruvo N, Tarantino G, DAmico G, Ballarin R, et al.
J Surg Oncol
. 2011 Jul;
105(1):111-2.
PMID: 21792942
No abstract available.